Cargando…
Comparison of the Metabolic Syndrome Risk in Valproate-Treated Patients with Epilepsy and the General Population in Estonia
BACKGROUND: No study has explored the risk of metabolic syndrome (MS) in patients with epilepsy treated with valproate (VPA) at the population level. The aim of this study was to compare the risk of MS in VPA-treated patients in Estonia to the risk in the general population. METHODS: This study invo...
Autores principales: | Rakitin, Aleksei, Eglit, Triin, Kõks, Sulev, Lember, Margus, Haldre, Sulev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117573/ https://www.ncbi.nlm.nih.gov/pubmed/25078464 http://dx.doi.org/10.1371/journal.pone.0103856 |
Ejemplares similares
-
Changes in the Peripheral Blood Gene Expression Profile Induced by 3 Months of Valproate Treatment in Patients with Newly Diagnosed Epilepsy
por: Rakitin, Aleksei, et al.
Publicado: (2015) -
Metabolic Syndrome in Estonia: Prevalence and Associations with Insulin Resistance
por: Eglit, Triin, et al.
Publicado: (2012) -
Obesity, High-Molecular-Weight (HMW) Adiponectin, and Metabolic Risk Factors: Prevalence and Gender-Specific Associations in Estonia
por: Eglit, Triin, et al.
Publicado: (2013) -
Smoking-related general and cause-specific mortality in Estonia
por: Kõks, Gea, et al.
Publicado: (2017) -
Creutzfeldt-Jakob Disease Presenting as Nonconvulsive Status Epilepticus
por: Rakitin, Aleksei, et al.
Publicado: (2018)